UNSPSC 51151654: Obidoxime

This classification denotes an anticholinergic agent with the molecular formula C14H16N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N6KNE1QA9O, chemically known as 4,4-bis-(hydroxyiminomethyl)-1,1-oxydimethylen-dipyridinium-kation but generally known as obidoxime, which bears US NIH Compound Identifier 5485192. European Medicines Agency schedules Obidoxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14676MIG.

UNSPSC 51151654 Obidoxime, a Commodity code, covers pharmaceutical products and related health-supply procurement by state and local health authorities. Recent state and local opportunities under this code show solicitation of naloxone and drug-deactivation systems for community health initiatives and exploratory procurement related to direct-to-manufacturer prescription models. The issuing bodies are county health departments and state health and human services agencies pursuing competitive procurement to support public health missions—specifically, opioid-overdose response and prescription-fulfillment optimization. Procurement mechanisms include invitational bidding (IFB) for specific product quantities and requests for information (RFI) for vendor capability assessment prior to formal solicitation.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug-deactivation systems annually with a response deadline of July 26, 2023, for quarterly delivery to the Seminole County Community Health Building in Sanford, with E-Verify compliance and drug-free workplace certification required. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to assess vendor capabilities for direct-to-manufacturer prescription programs serving self-insured employers and state agencies, focusing on negotiated net-pricing models and outcomes-based contracting strategies. Florida and Texas represent the primary recent jurisdictions with documented activity under this code. No other states or issuing bodies appear in the current opportunity record.